| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |